Sydney Antibody Therapeutics
Conference
7th & 8th May 2025
Join us for two days featuring the experts showcasing the latest in antibody research and technology


Speakers
Meet our Speakers
President of the Antibody Society (2022-2023), Professor of Molecular Immunology and Director of Translational Immunology, University of Southampton
local & international speakers
Adam Clarke
AbCellera Biologics
Alvin Chew
GenScript
Ben Kiefel
Myrio Tx
Brad Walsh
GlyTherix
Christoph Hagemeyer
Monash University
Colby Souders
Twist Bioscience
Chris Smith
Brandon Capital
Clarissa Whitehead
Burnett Institute
Daniel Christ
Garvan Institute
Hayley Ramshaw
Monash University
Jason Gill
Teva Pharmaceuticals
Kailash Kumar Vinu
Actimo Labs
Karlheinz Peter
Melbourne University
Lisa Williams
Alkira Bio
Maggie Ma
Promega
Martha Perez
Unchained Labs
Peter Janes
La Trobe University
Ross Dickins
Monash University
Sacha Zinn
Garvan Institute
Steve Gledhill
FB Rice
Final list to be announced at the end of March
Program
Day 1
7th May 2025
KEYNOTE

Greg Winter
Cambridge University
A tale of two antibodies

Adam Clarke
AbCellera Biologics
AbCellera's TCE platform
SESSION ONE – ANTIBODIES IN CARDIOLOGY
Karlheinz Peter
Melbourne University
Single chain antibodies for theranostic approaches in cardiovascular diseases
Christoph Hagemeyer
Monash University
Conformation-Specific Antibodies for the Therapy of Vascular Disease
SESSION TWO – ANTIBODIES IN ONCOLOGY
Jason Gill
Teva Pharmaceuticals
Novel approaches to cancer immunotherapy: Next generation Immunocytokines
Peter Janes
La Trobe University
Novel antibody drug conjugates targeting tumours and their microenvironment
Ben Kiefel
Myrio Tx
Retained Display (ReD)TM: Myrio Therapeutics’ leading technology for discovery of peptide-HLA binders.
Ross Dickins
Monash University
Immunosuppressive biologics targeting the CD80:PD-L1 duplex
Brad Walsh
GlyTherix
Development of a novel tumour targeting chimeric antibody - Miltuximab
SESSION THREE – NEW TARGETS
Alvin Chew
GenScript
Next-Gen Biologics Production: Case Studies from mAbs to Overcoming BsAb Challenges
Lisa Williams
Alkira Bio
A LASEREDD focus on GPCR-targeting antibodies
Remy Robert
Monash University
Antibody mediated depletion of pathogenic cells through their chemokine receptor signatures
Day 2
8th May 2025
KEYNOTE

Juliet Gerrard
University of Aukland
Science and science advice in New Zealand: a changing landscape

Daniel Christ
Garvan Institute
Targeting challenging antigens with monoclonal antibodies
SESSION FOUR – ANTIBODY IP AND CAPITAL LANDSCAPE
Steve Gledhill
FB Rice
Antibody patents – challenges and strategies
Chris Smith
Brandon Capital
The Antibody Therapeutics Landscape: An Australian VC Perspective
SESSION FIVE – PITCH PRESENTATIONS
Sacha Zinn
Garvan Institute
Enhancing immunisations using mRNA encoded antibodies
Kailash Kumar Vinu
Actimo Labs
ActiMap – Advancing Epitope Mapping Through AI-Driven In-Silico Modeling
Maggie Ma
Promega
Advancing Immunotherapy Development with Comprehensive Fc Effector Function Assays
Hayley Ramshaw
Monash Univiersity
Monash Antibody Discovery Platform Beacon Antibody Discovery instrument
SESSION SIX – ANTIBODY ENGINEERING FOR FUNCTION
KEYNOTE

Sally Ward
University of Southhampton
Targeting FcRn for the therapy of autoimmunity
Clarissa Whitehead
Burnett Institute
Stellabody® transforms the potency of antibody and Ig-like biologics.
Colby Souders
Twist Bioscience
Leveraging De Novo Sequence Design and DNA Writing for Target-Specific in vitro Library Discovery
Venue
CONFERENCE
Join us at the N’Galawa Terrace in the Taronga Centre at Taronga Zoo
ACCOMMODATION
Stay at the zoo
Enjoy an overnight stay at Taronga Zoo Sydney for a truly unique and immersive experience amongst the wild.
Sponsors
Sponsors






Want to be a Sponsor?
Contact us with the form below to learn more about sponsorship opportunities.
Silver level sponsorships are still available
Take this unique opportunity to gain brand awareness and visibility within the Australian and International Antibody Therapeutic community
Contact Us
